Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 1

Characteristics of subjects with and without metabolic syndrome.

	All	With metabolic syndrome	Without metabolic syndrome	P value
	( 29,797)	()	( 21,233)
BMI,				<0.001
Age,				<0.001
Sex (M/F) (%)	16,098/13,699	6525/2039	9573/11,660	<0.001
	(54.0/46.0)	(76.2/23.8)	(45.1/54.9)
WC,				<0.001
SBP,				<0.001
DBP,				<0.001
Fasting glucose, mg/				<0.001
Cholesterol, mg/				<0.001
HDL, mg/				<0.001
LDL, mg/				<0.001
TG, mg/				<0.001
AST, IU/				<0.001
ALT, IU/				<0.001
GGT, IU/				<0.001
Platelet,				<0.001
Fatty liver (yes/no) (%)	13,255/16,542	6295/2269	6960/14,273	<0.001
	(44.5/55.5)	(73.5/26.5)	(32.8/67.2)
FLI				<0.001
LAP				<0.001

as mean standard deviation.
BMI, body mass index; M, male; F, female; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; FLI, fatty liver index; LAP, lipid accumulation product.